Health ❯ Healthcare

Vaccine Efficacy

Clinical Trials mRNA Vaccines Antibody Response Vaccine Safety Dengue Virus Booster Shots Hospital Admissions Immunization Schedules Infection Risks COVID-19 Clinical Research Incidence Rates Comparative Studies Efficacy Studies Immunology Benefit-Risk Assessment Immunization Vaccine Research Comparative Effectiveness

6 ARTICLES

3mo ago

FDA Panel Weighs Moderna’s Bid for First U.S. mRNA Flu Vaccine

A favorable advisory vote could clear a faster, reformulatable mRNA platform for U.S. use while requiring confirmatory studies to address gaps for older adults.

6 ARTICLES

last yr.

Cochrane Review Finds RSV Vaccines Protect Older Adults and Infants Without Raising Serious Risks

5 ARTICLES

last yr.

Moderna’s mRNA-1010 Flu Vaccine Shows Superior Efficacy in Phase 3 Trial

5 ARTICLES

last yr.

Vaccine Efficacy

FDA Panel Weighs Moderna’s Bid for First U.S. mRNA Flu Vaccine

Cochrane Review Finds RSV Vaccines Protect Older Adults and Infants Without Raising Serious Risks

Moderna’s mRNA-1010 Flu Vaccine Shows Superior Efficacy in Phase 3 Trial

Trans-amplifying mRNA vaccine delivers broad SARS-CoV-2 variant protection with 40-fold lower dosage